TY - JOUR
T1 - Coronary artery calcification progression and renal involvement in patients with systemic lupus erythematosus
T2 - a longitudinal cohort study
AU - Zinglersen, Lise
AU - Zinglersen, Amanda Hempel
AU - Myhr, Katrine Aagaard
AU - Hermansen, Marie-Louise
AU - Kofoed, Klaus Fuglsang
AU - Fuchs, Andreas
AU - Diederichsen, Louise P
AU - Jacobsen, Søren
N1 - © 2025. The Author(s).
PY - 2025/1/13
Y1 - 2025/1/13
N2 - To investigate if progression of coronary artery calcification (CAC) in patients with systemic lupus erythematosus (SLE) is associated with renal and traditional cardiovascular risk factors as well as incidence of myocardial infarctions. CAC progression was evaluated by cardiac computed tomography (CT) at baseline and after 5 years. Multivariable Poisson regression was applied to investigate associations between CAC progression and baseline values for traditional cardiovascular risk factors, CAC, SLE disease duration, lupus nephritis, and renal function. Regarding renal function, three groups were defined based on eGFR. Further, we analysed association between CAC progression and myocardial infarction during follow-up. Of the 147 SLE patients, 99 had cardiac CT at baseline and 5-year follow-up, with a total of 502 patient-years. At baseline, their median age was 47 years, median SLE disease duration was 14 years, 88% were women, 58% had lupus nephritis, and the median eGFR was 99 mL/min/1.73m2. 38/99 (39%) had CAC progression. CAC progression was associated with smoking (ever) (relative risk [RR] 1.69, CI95% 1.19-2.40), SLE disease duration (RR per year 1.03, CI95% 1.01-1.04), and CAC presence (RR 2.52, CI95% 1.68-3.78) at baseline. During follow-up, myocardial infarction occurred in three (7.9%) CAC progressors and in two (3.3%) patients who did not have CAC at any time (RR 2.1, CI95% 0.0-5.5). In this study, progression of CAC was associated with smoking, SLE disease duration and the prior presence of CAC, but it was inconclusive as to associations with renal involvement and incidence of MI.
AB - To investigate if progression of coronary artery calcification (CAC) in patients with systemic lupus erythematosus (SLE) is associated with renal and traditional cardiovascular risk factors as well as incidence of myocardial infarctions. CAC progression was evaluated by cardiac computed tomography (CT) at baseline and after 5 years. Multivariable Poisson regression was applied to investigate associations between CAC progression and baseline values for traditional cardiovascular risk factors, CAC, SLE disease duration, lupus nephritis, and renal function. Regarding renal function, three groups were defined based on eGFR. Further, we analysed association between CAC progression and myocardial infarction during follow-up. Of the 147 SLE patients, 99 had cardiac CT at baseline and 5-year follow-up, with a total of 502 patient-years. At baseline, their median age was 47 years, median SLE disease duration was 14 years, 88% were women, 58% had lupus nephritis, and the median eGFR was 99 mL/min/1.73m2. 38/99 (39%) had CAC progression. CAC progression was associated with smoking (ever) (relative risk [RR] 1.69, CI95% 1.19-2.40), SLE disease duration (RR per year 1.03, CI95% 1.01-1.04), and CAC presence (RR 2.52, CI95% 1.68-3.78) at baseline. During follow-up, myocardial infarction occurred in three (7.9%) CAC progressors and in two (3.3%) patients who did not have CAC at any time (RR 2.1, CI95% 0.0-5.5). In this study, progression of CAC was associated with smoking, SLE disease duration and the prior presence of CAC, but it was inconclusive as to associations with renal involvement and incidence of MI.
KW - Humans
KW - Female
KW - Middle Aged
KW - Male
KW - Lupus Erythematosus, Systemic/complications
KW - Disease Progression
KW - Coronary Artery Disease/epidemiology
KW - Longitudinal Studies
KW - Adult
KW - Vascular Calcification/epidemiology
KW - Myocardial Infarction/epidemiology
KW - Lupus Nephritis/epidemiology
KW - Glomerular Filtration Rate
KW - Risk Factors
KW - Incidence
KW - Tomography, X-Ray Computed
UR - http://www.scopus.com/inward/record.url?scp=85215354446&partnerID=8YFLogxK
U2 - 10.1007/s00296-025-05785-8
DO - 10.1007/s00296-025-05785-8
M3 - Journal article
C2 - 39804493
SN - 0172-8172
VL - 45
SP - 26
JO - Rheumatology International
JF - Rheumatology International
IS - 1
M1 - 26
ER -